Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
Protecting Consumer Access to Generic Drugs Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2009 · third_quarter · Q3
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2009 · second_quarter · Q2
Source: Senate LDA
Protecting Consumer Access to Generic Drugs Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, "Preserve Access to Affordable Generics Act"; H.R.1902, "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Protecting Consumer Access to Generic Drugs Act of 2007
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, "Preserve Access to Affordable Generics Act"; H.R.1902, "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Protecting Consumer Access to Generic Drugs Act of 2007
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Protecting Consumer Access to Generic Drugs Act of 2007
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, "Preserve Access to Affordable Generics Act"; H.R.1902, "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Protecting Consumer Access to Generic Drugs Act of 2007
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Patent litigation settlement legislation, including S.316, "Preserve Access to Affordable Generics Act"; H.R. 1902, "Protecting Consumer Access to Generic Drugs Act of 2007".
Protecting Consumer Access to Generic Drugs Act of 2007
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Patent litigation settlement legislation, including S. 316, "Preserve Access to Affordable Generics Act"; H.R. 1902, "Protecting Consumer Access to Generic Drugs Act of 2007".
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Regulation of settlements of pharmaceutical patent litigation, including but not limited to S.316.
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Patent litigation settlement legislation, including S. 316, "Preserve Access to Affordable Generics Act"; H.R. 1902, "Protecting Consumer Access to Generic Drugs Act of 2007".
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: WILLKIE FARR & GALLAGHER LLP
Patent litigation settlement legislation, including S.316, "Preserve Access to Affordable Generics Act"; H.R. 1902, "Protecting Consumer Access to Generic Drugs Act of 2007".
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2009 · first_quarter · Q1
Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2008 · third_quarter · Q3
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2008 · second_quarter · Q2
Lobbying issues - Settlement of patent infringement claims, including S. 316, the "Preserve Access to Affordable Generics Act"; H.R. 1902, the "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
Filing targets: Congressional Budget Office (CBO)
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2008 · first_quarter · Q1
Lobbying issues - Settlement of patent infringement claims, including S. 316, "Preserve Access to Affordable Generics Act"; H.R.1902, "Protecting Consumer Access to Generic Drugs Act of 2007"; and H.R. 1432, the "Preserve Access to Affordable Generics Act."
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2007 · year_end · YY
Patent litigation settlement legislation, including S.316, "Preserve Access to Affordable Generics Act"; H.R. 1902, "Protecting Consumer Access to Generic Drugs Act of 2007".
Filing targets: HOUSE OF REPRESENTATIVES
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2007 · mid_year · MM
Patent litigation settlement legislation, including S. 316, "Preserve Access to Affordable Generics Act"; H.R. 1902, "Protecting Consumer Access to Generic Drugs Act of 2007".
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA INC via WILLKIE FARR & GALLAGHER LLP
2007 · mid_year · RR
Regulation of settlements of pharmaceutical patent litigation, including but not limited to S.316.
HYNIX SEMICONDUCTOR INC via WILLKIE FARR & GALLAGHER LLP
2003 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
DUN & BRADSTREET via WILLKIE FARR & GALLAGHER LLP
2001 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOMBERG L P via WILLKIE FARR & GALLAGHER LLP
2001 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOMBERG L P via WILLKIE FARR & GALLAGHER LLP
2000 · year_end · YY
BLOOMBERG L P via WILLKIE FARR & GALLAGHER LLP
2000 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES
BLOOMBERG L P via WILLKIE FARR & GALLAGHER LLP
1999 · year_end · RR
BLOOMBERG L P via WILLKIE FARR & GALLAGHER LLP
1999 · year_end · RR
DUN & BRADSTREET via WILLKIE FARR & GALLAGHER LLP
1999 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES